Tidal Investments LLC bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 69,346 shares of the real estate investment trust's stock, valued at approximately $1,586,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. State Street Corp acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $1,093,576,000. Geode Capital Management LLC bought a new position in Healthpeak Properties in the third quarter valued at approximately $403,898,000. Charles Schwab Investment Management Inc. acquired a new stake in Healthpeak Properties during the 3rd quarter worth $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. bought a new position in shares of Healthpeak Properties in the 3rd quarter worth $102,615,000. Institutional investors own 93.57% of the company's stock.
Healthpeak Properties Stock Performance
Shares of NYSE:DOC traded down $0.89 on Wednesday, reaching $19.98. 4,300,466 shares of the company's stock were exchanged, compared to its average volume of 5,626,965. The company has a fifty day moving average of $21.90 and a 200-day moving average of $21.40. The company has a market capitalization of $13.97 billion, a price-to-earnings ratio of 42.51, a PEG ratio of 2.37 and a beta of 1.13. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. Healthpeak Properties, Inc. has a twelve month low of $16.01 and a twelve month high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The company had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. During the same period last year, the firm earned $0.45 EPS. The firm's revenue for the quarter was up 25.9% compared to the same quarter last year. On average, research analysts predict that Healthpeak Properties, Inc. will post 1.8 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.01%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties's payout ratio is presently 255.32%.
Analysts Set New Price Targets
Several equities research analysts have weighed in on DOC shares. StockNews.com lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Wednesday, October 30th. Scotiabank increased their target price on Healthpeak Properties from $23.00 to $24.00 and gave the stock a "sector outperform" rating in a report on Monday, September 9th. Evercore ISI upped their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the stock an "outperform" rating in a research report on Monday, September 16th. Citigroup boosted their target price on Healthpeak Properties from $20.00 to $22.00 and gave the company a "neutral" rating in a research note on Thursday, August 22nd. Finally, Robert W. Baird lifted their price objective on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an "outperform" rating in a report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Healthpeak Properties has an average rating of "Moderate Buy" and an average price target of $22.93.
Get Our Latest Report on DOC
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.